Skip to main
SYN

Synthetic Biologics (SYN) Market Capitalization Overview

Market Cap: $7.79M as of Jan 12, 2026

$7.79M
$448.50K (6.12%)past month
As of Jan 12, 2026, Synthetic Biologics (SYN) has a market capitalization of $7.79M. Over the past 30 days, its market cap has increased by 18.23%, while in the last 12 months, it has increased by 9.26%.

Market capitalization represents the total value of Synthetic Biologics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Synthetic Biologics (SYN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Synthetic Biologics (SYN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Synthetic Biologics (SYN) Market Cap History

DateMarket CapChange
Dec 1, 2025$7.39M-32.65%
Nov 3, 2025$10.97M+184.20%
Oct 1, 2025$3.86M-1.42%
Sep 2, 2025$3.92M-0.24%
Aug 1, 2025$3.93M-1.12%
Jul 1, 2025$3.97M-0.81%
Jun 2, 2025$4.01M+2.69%
May 1, 2025$3.90M+25.00%
Apr 1, 2025$3.12M-15.79%
Mar 3, 2025$3.71M+10.84%
Feb 3, 2025$3.34M-27.27%
Jan 2, 2025$4.60M+19.56%

Synthetic Biologics (SYN) End of Year Market Cap History

DateMarket CapChange
2026$7.79M+9.26%
2025$7.13M+46.24%
2024$4.87M-33.57%
2023$7.34M+1.72%
2022$7.21M-79.95%
2021$35.95M

FAQs About Synthetic Biologics (SYN) Market Cap

As of Jan 12, 2026, the market capitalization of Synthetic Biologics (SYN) is $7.79M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Synthetic Biologics’s market capitalization has increased by 6.12%, changing from $7.34M to $7.79M as of Jan 12, 2026.

In the last 3 months, Synthetic Biologics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Synthetic Biologics’s market capitalization increased from $4.87M in January to $7.13M in December, reflecting a 46.24% change.

In the past five years, Synthetic Biologics (SYN) has had a compound annual growth rate (CAGR) of -27.66% in market capitalization. This means its market cap has shrunk at an average rate of -27.66% per year.

Synthetic Biologics (SYN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.